These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 39037571)

  • 1. SPP1 could be an immunological and prognostic biomarker: From pan-cancer comprehensive analysis to osteosarcoma validation.
    Zhang Z; Liu B; Lin Z; Mei L; Chen R; Li Z
    FASEB J; 2024 Jul; 38(14):e23783. PubMed ID: 39037571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
    Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis to identify PUS7 as a prognostic biomarker from pan-cancer analysis to osteosarcoma validation.
    Dong B; Wang B; Fan M; Zhang J; Zhao Z
    Aging (Albany NY); 2024 May; 16(10):9188-9203. PubMed ID: 38819212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer.
    Yang Z; Xu D; Ye X; Lin X; Zhang M; Su Y; Xie Q; Ni W
    Biomed Res Int; 2022; 2022():3924400. PubMed ID: 35252444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secreted phosphoprotein 1 as a potential prognostic and immunotherapy biomarker in multiple human cancers.
    Zeng P; Zhang X; Xiang T; Ling Z; Lin C; Diao H
    Bioengineered; 2022 Feb; 13(2):3221-3239. PubMed ID: 35067176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifies microtubule-binding protein
    Wang W; Zhang J; Wang Y; Xu Y; Zhang S
    Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
    Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
    Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma.
    Dalla-Torre CA; Yoshimoto M; Lee CH; Joshua AM; de Toledo SR; Petrilli AS; Andrade JA; Chilton-MacNeill S; Zielenska M; Squire JA
    BMC Cancer; 2006 Oct; 6():237. PubMed ID: 17022822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive investigation of tumor immune microenvironment and prognostic biomarkers in osteosarcoma through integrated bulk and single-cell transcriptomic analysis.
    Shi S; Zhang L; Guo X
    Front Immunol; 2024; 15():1424950. PubMed ID: 39108264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXB9 promotes osteosarcoma cell survival and malignancy under glucose starvation via upregulating SPP1 expression.
    Han J; Ji R; Zheng S; Xia X; Du W; He H; Han C; Zhao W; Li X; Wang Y; Zhang L
    Biochem Pharmacol; 2024 Jun; 224():116208. PubMed ID: 38621423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-cancer and single-cell analysis reveal dual roles of lymphocyte activation gene-3 (LAG3) in cancer immunity and prognosis.
    Wang Y; Zhao Y; Zhang G; Lin Y; Fan C; Wei H; Chen S; Guan L; Liu K; Yu S; Fu L; Zhang J; Yuan Y; He J; Cai H
    Sci Rep; 2024 Oct; 14(1):24203. PubMed ID: 39406840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA circ-NT5C2 acts as a potential novel biomarker for prognosis of osteosarcoma.
    Nie WB; Zhao LM; Guo R; Wang MX; Ye FG
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6239-6244. PubMed ID: 30338784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDE1B, a potential biomarker associated with tumor microenvironment and clinical prognostic significance in osteosarcoma.
    Chen Q; Xing C; Zhang Q; Du Z; Kong J; Qian Z
    Sci Rep; 2024 Jun; 14(1):13790. PubMed ID: 38877061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-cancer analysis from multi-omics data reveals AAMP as an unfavourable prognostic marker.
    Wang Y; Liu T; Zhang K; Huang RH; Jiang L
    Eur J Med Res; 2023 Jul; 28(1):258. PubMed ID: 37501187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of TNFRSF1A as a potential biomarker for osteosarcoma.
    Zhang Y; Liu K; Wang J
    Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-Cancer Analysis Revealed
    Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J
    J Oncol; 2022; 2022():3477148. PubMed ID: 35069733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
    Yang H; Zhao L; Zhang Y; Li FF
    Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value and immunological role of PDCD1 gene in pan-cancer.
    Miao Y; Wang J; Li Q; Quan W; Wang Y; Li C; Wu J; Mi D
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107080. PubMed ID: 33069926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.